Back
The Toronto-Dominion Bank Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Buy
54
TD
The Toronto-Dominion Bank
Last Price:
$93.05
Seasonality Move:
4.95%
Sell
34
MNPR
Monopar Therapeutics, Inc.
Last Price:
$70.95
Seasonality Move:
25.93%
Buy
54
The Toronto-Dominion Bank (TD)
is a Buy
Is The Toronto-Dominion Bank a Buy, Sell or Hold?
-
The current The Toronto-Dominion Bank [TD] share price is $92.82. The Score for TD is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
TD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $68.63. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TD Stock Price Chart
What is The Toronto-Dominion Bank's stock price today?
-
The The Toronto-Dominion Bank share price today is $92.82Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TD is experiencing slight selling pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $68.63Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.
TD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 17.35 | Buy |
| Relative Strength Index (14 RSI): | 78.15 | Buy |
| Chaikin Money Flow: | -1023251 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (82.21 - 90.69) | Buy |
| Bollinger Bands (100): | (74.76 - 85.04) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.61 | Sell |
| Relative Strength Index (14 RSI): | 37.25 | Sell |
| Chaikin Money Flow: | 166161 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (72.18 - 85.74) | Sell |
| Bollinger Bands (100): | (45.57 - 89.21) | Buy |
TD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 91.84 | Buy |
| 20-day SMA: | 87.66 | Buy |
| 50-day SMA: | 83.61 | Buy |
| 200-day SMA: | 73.04 | Buy |
| 8-day EMA: | 48.87 | Buy |
| 20-day EMA: | 23.92 | Buy |
| 50-day EMA: | 10.43 | Buy |
| 200-day EMA: | 2.72 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.35 | Sell |
| 20-day SMA: | 78.65 | Sell |
| 50-day SMA: | 81.47 | Sell |
| 200-day SMA: | 52.32 | Buy |
| 8-day EMA: | 71.44 | Sell |
| 20-day EMA: | 75.9 | Sell |
| 50-day EMA: | 76.79 | Sell |
| 200-day EMA: | 56.68 | Buy |
The Toronto-Dominion Bank Earnings Growth & TD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.12 per share, an increase this year of $0.21 per share, and an increase next year of $0.75 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
The Toronto-Dominion Bank Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||